HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ONP Has Actual-Use Trial Panel, Rx-To-OTC Switch MaPP In Mind – Ganley

This article was originally published in The Tan Sheet

Executive Summary

FDA's Office of Nonprescription Products may examine issues surrounding actual-use trials for OTC drugs at an advisory committee meeting later this year

You may also be interested in...

FDA Sets Outcomes Benchmarks For Actual Use Trials

FDA is providing OTC switch application sponsors with pre-defined benchmarks for actual use trials, Center for Drug Evaluation and Research executive Andrea Leonard-Segal says

ONP’s Revised MaPP Routes Steps For Investigational New Drug Applications

FDA's Office of Nonprescription Products outlines oversight and workflow procedures for filing investigational new drug applications in a newly issued Manual of Policies and Procedures released by the Center for Drug Evaluation and Research

FDA Urges More Switch Sponsor Efforts At Pre-Clinical Stage

Firms submitting switch applications should put more focus on pre-clinical testing, according to Dr. Andrea Leonard-Segal, director of the Division of Nonprescription Clinical Evaluation in FDA's Center for Drug Evaluation and Research

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts